Vividion Therapeutics Investors

29 investors on Angel Roster list Vividion Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, Switzerland and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Vividion Therapeutics can appear together.

Investors listed
29
With verified email
38%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 29 Vividion Therapeutics investors

The most complete profiles first. Showing 29 of 29.

  • Brian AtwoodVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsCybersecurityWomen Founded

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 63 more

    Verified email available

  • Carol SuhVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • David CruikshankVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHardware

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Eli CasdinVerified

    Venture Capital, Founder, Micro VC · United States

    SeedHealth CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more

    Verified email available

  • Kristen WongVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Constellation Pharmaceuticals, Cero Therapeutics, Encoded Therapeutics, Siluria Technologies and 19 more

    Verified email available

  • Sean KendallVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareEnterprise SoftwareEnergyChemical

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Alexander MaywegVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Verified email available

  • JOHN CLARKEVerified

    Micro VC · United States

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Melinta, Cureatr, AxoGen, Verastem Oncology and 24 more

    Verified email available

  • Mark McDonnellVerified

    Venture Capital · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Tom BrennanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Tom McKinleyVerified

    Micro VC · United States

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Melinta, Cureatr, AxoGen, Verastem Oncology and 24 more

    Verified email available

  • Carlo Rizzuto

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 60 more

    Contact details available

  • Charles Warden

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 61 more

    Contact details available

  • Corey Ritter

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceRoboticsManufacturing

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Dave Maki

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Constellation Pharmaceuticals, Cero Therapeutics, Encoded Therapeutics, Siluria Technologies and 19 more

    Contact details available

  • Kristina Burow

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: Lycera, Kilimanjaro Energy, Orbital Therapeutics, Vividion Therapeutics and 6 more

    Contact details available

  • Nilay Thakar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Ross Jaffe

    Venture Capital, Investor · United States

    Series BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 59 more

    Contact details available

  • Steve Gillis

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more

    Contact details available

  • Thomas Lips

    Venture Capital, Private Equity Firm, Investor · Switzerland

    SeedHealth CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Black Diamond Therapeutics, Blueprint Medicines, TRACON Pharmaceuticals, Jounce Therapeutics and 30 more

    Contact details available

  • Adeline Oursler

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Beckie Robertson

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Bill Link

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Cody Tranbarger

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Don Milder

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Jonathan Kabakoff

    Corporate Venture Capital · United States

    Health CareWomen FoundedChemicalLife Science

    Portfolio: Molecular Assemblies, Syros Pharmaceuticals, EpiBiome, Immunitas Therapeutics and 30 more

    Contact details available

  • Norman Zhou

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Black Diamond Therapeutics, AveXis, Aligos Therapeutics, Tyra Biosciences and 46 more

    Contact details available

  • Paul Grayson

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Robert Nelsen

    Venture Capital, Investor · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more

    Contact details available

Frequently asked questions

How many Vividion Therapeutics investors are on Angel Roster?

Angel Roster lists 29 Vividion Therapeutics investors. 11 of them (38%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (24), Private Equity Firms (10) and Micro VC Firms (5). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Vividion Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (8), Series B (7) and Pre-Seed (1).

Where are Vividion Therapeutics investors based?

Most are based in the United States (26), Switzerland (2) and the United Kingdom (1).

Which companies have Vividion Therapeutics investors backed?

The most-backed portfolio companies among them are Codiak Biosciences (14), Beam Therapeutics (14), EQRx (13), Insitro (12) and Gritstone Oncology (12).

How do I contact Vividion Therapeutics investors?

Create a free Angel Roster account to search and filter all 29, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.